Pharmaceutical Industry Reports Rivaroxaban market Click to read
  • Comments

Pharmaceutical Industry Reports

Rivaroxaban market

Published on in “Health & Fitness, Science”, language — English. 8 pages.
Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto. Anticoagulant medicines are potent therapeutic agents used in the prevention or treatment of serious illnesses and potentially life-threatening conditions associated with blood coagulation. More
Nanobodies are considered to be one of the best technology in the fields of research, diagnostics and therapy especially in cancer research. More

Other publications of “Pharmaceutical Industry Reports”

View all publications